VP Business Development – CRO and Pharma – USA East Coast

VP BUSINESS DEVELOPMENT – CRO and PHARMA – USA East Coast

Compumedics Limited (ASX: CMP) is a leading medical device company involved in the development, manufacture and commercialization of diagnostics technology for sleep,
neurology and ultrasonic blood-flow monitoring applications. The Company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. In conjunction with these two
subsidiaries, Compumedics has a broad international reach, including Americas; Australia and Asia Pacific; and Europe and the Middle East.

The CRO and Pharma Business Development Executive is part of the Compumedics US business team and reports directly to the Business Development Manager, based in New Zealand.

This role requires strong clinical and technical capabilities, a good understanding of GCP, excellent communication skills, and the ability to identify and engage the target customers to ultimately select the Compumedics Sleep and EEG hardware and SaaS solutions for their research requirements.

Essential Duties and Responsibilities:

• Develop a deep understanding of the Compumedics Sleep and EEG hardware, software and SaaS product offering.
• Develop and maintain a CRM database of potential Pharma and CRO clients, their new product pipelines and sleep and EEG related requirements.
• Attend appropriate Pharma/CRO exhibitions, seminars and events to promote the Compumedics capabilities and to identify and secure new clients.
• Instigate contact with new potential Pharma/CRO customers, present the Compumedics product and capabilities and secure their business.
• Negotiate scope of services, pricing and contractual terms for all new customers in conjunction with the Business Development Manager and CFO.
• Personally onboard and train all new Pharma/CRO customers on Compumedics product and capabilities.
• Personally train CRO and study site staff, where required.
• Provide reliable visibility on new opportunities and revenue forecasts vis CMP CRM system.
• Maintain existing client relationships, ensuring we maintain a preferred partner status and continue to be the preferred solutions partner for their Sleep and EEG monitoring requirements.

Role Requirements:

• Experienced with the CRO clinical trials management process and Pharma drug development processes with a reasonable understanding of GCP.
• An independent minded, self-motivated, experienced Business Development Executive (minimum 5 years in a similar role preferred) who is confident and capable of engaging the Pharma/CRO Device Technologies decision makers with Compumedics solutions.
• Personally efficient with very good presentation skills.
• Exceptional organizational skills, the capacity to successfully manage competing priorities, maintain attention to detail and manage time effectively.
• US East Coast based.

 
Role Experience Requirement:

• Minimum of 5+ years Business development targeting Pharma/CRO organisations with clinical trials hardware, software or SaaS solutions.
• High level of computer literacy including Microsoft 365 suite and CRM.

 
Travel Required:

• Required to Travel interstate within the US and Canada (Up to 40% of the time)
• Required to do some International Travel (Up to 10% of the time)
• Required to have a valid Driver’s License

 
Home Based:

• USA (East coast)

About the Company:

Compumedics, founded in 1987, is a global leader in the design & manufacture of innovative diagnostic technologies for sleep disorders, neurophysiology & cardiology.

In 1987, Compumedics established Asia Pacific’s first fully computerised sleep lab and holds 80% share of the Australian sleep-diagnostic market and has a major & rapidly growing presence in the US, European & Asian markets for its sleep, neurological, & Doppler blood flow diagnostic monitoring devices.

In 1995, the company was selected to supply equipment to the US Sleep Heart Health Study, the world’s largest sleep study of its kind, currently exceeding 14,000 studies with 20,000 patients scheduled by 2008.

With headquarters in Melbourne, Australia & offices in the US & Europe, the products are distributed in over 50 countries.

Achievements include:

• 1998 Australian Exporter of the Year 2000 Listed on the Australian Stock Exchange
• 2002 Acquired US-based Neuroscan, the world’s leading supplier of instruments for brain research. Neuroscan holds about 90% of the USA market for brain research products
• 2003 Frost & Sullivan Award for Market Expansion Strategy
• 2004 Acquired German-based DWL Elektronishe GmbH
• 2006 Frost & Sullivan Technology Leadership award for the innovative Somté
• 2007 Victorian Manufacturing Hall of Fame
• 2008 The DWL division received the top 100 German Innovation award
• 2009 Design award for its Grael™ PSG/EEG premium lab solution
• 2010 Recognised as Australia’s top 100 health innovators
• 2011 Established direct presence in France, awarded several significant USA contracts to supply preeminent USA customers with NeuvoLTM EEG
• 2012 Celebrated 25 year silver jubilee anniversary, CURRY7 and Neuvo 512 LTM EEG system released
• 2013 Equity issued to Beijing Bestmed, its long-term partner in China
• 2014 Released Upgrade to the world leading diagnostics software platform for Sleep and EEG, ProFusion
• 2015 Core business strengthens and returns to strong operating profitability